Certain Shares of Formycon AG are subject to a Lock-Up Agreement Ending on 2-AUG-2023.
Details:
Following the private placement, Formycon will be subject to a lock-up obligation with market-standard exemptions for a period of six months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.2 EUR | +5.37% | +8.14% | -23.40% |
Apr. 25 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
1st Jan change | Capi. | |
---|---|---|
-23.40% | 822M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |